These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6024280)

  • 41. [The combined treatment of locally disseminated stomach cancer with intra-arterial regional chemotherapy].
    Zyrianov BN; Makarkin NA; Tikhonov VI; Tuzikov SA
    Khirurgiia (Mosk); 1996; (6):13-6. PubMed ID: 9173142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer.
    Fujimoto S; Akao T; Itoh B; Koshizuka I; Koyano K
    Ann Surg; 1977 Apr; 185(4):462-6. PubMed ID: 320951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the safety of recombinant interleukin-2 (rIL-2) and rIL-2 plus 5-fluorouracil (5-FU) in the adjuvant treatment of gastric cancer patients.
    Ubhi SS; Hollingworth J; Horsburgh T; Veitch PS; Roest G; Palmer P; Franks CR; Bell PR
    Anticancer Res; 1992; 12(3):749-52. PubMed ID: 1622133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy of 5-fluorouracil and low-dose cisplatin in advanced and recurrent gastric cancer: a multicenter retrospective study in Nagasaki, Japan.
    Enjoji A;
    Anticancer Res; 2002; 22(2B):1135-9. PubMed ID: 12168913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On a method of treating patients with cancer of the stomach with 5-fluorouracil].
    Korman DB; Evseenko LS; Orlova RS
    Vopr Onkol; 1967; 13(12):61-5. PubMed ID: 5597533
    [No Abstract]   [Full Text] [Related]  

  • 47. Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
    Weissinger F; Reymond M; Dumke K; Krüger M
    Onkologie; 2011; 34(10):548-51. PubMed ID: 21985855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newer concepts in chemotherapy of cancer.
    Ansfield FJ; Mackman S; Ramirez G
    Oncology; 1972; 26(2):114-20. PubMed ID: 4559039
    [No Abstract]   [Full Text] [Related]  

  • 49. [Biochemical criteria of 5-fluorouracil sensitivity and resistance of stomach tumors].
    Shlemkevich MP
    Biull Eksp Biol Med; 1984 Nov; 98(11):555-6. PubMed ID: 6509172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The use of endolymphatic chemotherapy in patients with metastatic stomach cancer].
    Bondar' GV; Zabudkin AF; Bukhteev SV
    Klin Khir (1962); 1994; (5):3-5. PubMed ID: 7807894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin.
    Chan CH; Liu TW; Chen LT; Chang JY; Whang-Peng J
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1470-1. PubMed ID: 16105146
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prophylactic course of chemotherapy against the background of hyperthermia following radical surgery for gastric cancer].
    Dumbadze ND
    Klin Khir (1962); 1973 Jun; 6():31-4. PubMed ID: 4770962
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-fluoruracil therapy of cancer of the stomach.
    Blokhina NG
    Acta Med Pol; 1968; 9(4):407-15. PubMed ID: 5700824
    [No Abstract]   [Full Text] [Related]  

  • 54. [Late results of the combined treatment of stomach cancer in relation to individual tumor sensitivity to 5-fluorouracil].
    Savran VR; Shiian DN
    Klin Khir (1962); 1981 May; (5):16-8. PubMed ID: 7253416
    [No Abstract]   [Full Text] [Related]  

  • 55. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical use of 5-fluorouracil in surgical field].
    Suzuki T; Nishimura G; Imamura K; Sugahara K; Fujii Y
    Gan No Rinsho; 1969 May; 15(5):459-68. PubMed ID: 5387578
    [No Abstract]   [Full Text] [Related]  

  • 57. A phase III randomized study comparing oral doxifluridine and oral 5-fluorouracil after curative resection of gastric cancer.
    Takiguchi N; Nakajima N; Saitoh N; Fujimoto S; Nakazato H
    Int J Oncol; 2000 May; 16(5):1021-7. PubMed ID: 10762640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
    Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1029-32. PubMed ID: 8210253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The phagocytic activity and cytochemical indices of the neutrophils in patients with stomach cancer treated with 5-fluorouracil].
    Gusarov IuP; Gusarova LT
    Vopr Onkol; 1991; 37(2):231-3. PubMed ID: 2014708
    [No Abstract]   [Full Text] [Related]  

  • 60. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
    Falkson G; van Eden EB; Falkson HC
    Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.